Skip to content

Products

We’ve been providing innovative medicines to the UK since the 1920s; this is what our portfolio looks like today.

© 2025 NAPP PHARMACEUTICALS LIMITED. DOP: July 2024 UK-CORP-2200003 v10.0

Opioid Charter

For Mundipharma’s Charter on the responsible medical use of opioid analgesics in pain management click here.

Opioid Safety Statement

“Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is a requirement at initiation, maintenance and tapering down of opioid therapy.”

Napp
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.